NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, October 4th. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.68%. The ex-dividend date of this dividend is Tuesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analysts' expectations of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm's revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

19 Wall Street analysts have issued 1 year price objectives for CVS Health's stock. Their predictions range from $77.84 to $104.00. On average, they anticipate CVS Health's share price to reach $91.52 in the next year. This suggests a possible upside of 22.8% from the stock's current price. View Analyst Price Targets for CVS Health.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News headlines about CVS stock have trended somewhat negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

CVS Health saw a decline in short interest in the month of November. As of November 30th, there was short interest totalling 35,182,217 shares, a decline of 41.2% from the November 15th total of 59,852,649 shares. Based on an average daily volume of 10,480,873 shares, the days-to-cover ratio is currently 3.4 days. Approximately 2.7% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.33%), BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%), Dodge & Cox (1.48%) and Bank of New York Mellon Corp (1.23%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company , Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Clearbridge Investments LLC and Bridgewater Associates LP. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Dodge & Cox, Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Vanguard Group Inc., Senator Investment Group LP and HealthCor Management L.P.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $74.50.

CVS Health has a market capitalization of $75.48 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]